A Comparative Study of Medical Device Regulatory Frameworks: India vs. the European Union

The regulatory frameworks governing medical devices have become increasingly complex and crucial for ensuring patient safety and product efficacy due to rapid technical advancement and expanding international trade. This study examines the medical device regulatory frameworks of the European Union (EU) and India, focusing on device classification, approval processes, clinical evaluation, and post¬market surveillance requirements. India controls medical devices under the Medical Devices Rules (IMDR), 2017 and later amendments, whereas the EU operates under the Medical Device Regulation (MDR) 2017/745 and In Vitro Diagnostic Regulation (IVDR) 2017/746.Both regions employ risk-based classification systems, according to the report, but the EU framework—which is supported by CE marking, notified authorities, and centralized databases like EUDAMED—shows a more advanced, standardized, and globally recognized regulatory structure. On the other hand, India has achieved significant progress because of digital platforms like SUGAM and centralized regulatory oversight by CDSCO; yet, problems with post-market surveillance transparency and data accessibility persist. The study concludes that while India's regulatory ecosystem is steadily strengthening, greater regulatory alignment with international standards and convergence with the EU could improve patient safety, promote innovation, and facilitate the entry of medical devices into international markets.

The review also explains a brief about India and EU regulatory requirement for registration of medical device and comparative data between two countries.